Hans Preusting

Hans Preusting

Director/Board Member at MENDUS AB

62 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Hans Preusting is an Independent Director at Mendus AB and a Chief Executive Officer at Synerkine Pharma BV.
He is on the Board of Directors at Mendus AB, DCPrime BV, Oxyrane UK Ltd.
and PharmaCell BV.
Dr. Preusting was previously employed as a Director-Operations & Business Development by Amsterdam Molecular Therapeutics (AMT) Holding NV, a Director-Influenza & Cell Culture Vaccine by Solvay Pharmaceuticals BV, a Manager-Operations by DSM Biologics Holding, Inc., and a Chief Business Officer by uniQure NV.
He received his MBA from Rotterdam School of Management and a doctorate degree from Rotterdam School of Management.

Hans Preusting active positions

CompaniesPositionStart
MENDUS AB Director/Board Member 31/12/2020
Director/Board Member -
Director/Board Member -
Chief Executive Officer -
Director/Board Member 31/03/2019
All active positions of Hans Preusting

Former positions of Hans Preusting

CompaniesPositionEnd
Chief Operating Officer 10/03/2013
Corporate Officer/Principal 31/12/2005
Chief Operating Officer 31/12/2002
UNIQURE N.V. Chief Operating Officer 08/04/2014
See the detail of Hans Preusting's experience

Training of Hans Preusting

Rotterdam School of Management Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans Preusting's experience

Connections

54

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MENDUS AB

Health Technology

UNIQURE N.V.

Health Technology

Private companies7

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Hans Preusting